Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Tocagen patents

List of Tocagen patents

List of Kurume University patents

List of Amerityre patents

List of Alltranz Limited patents

List of awards received by Mike Grob

List of funding rounds for SANTA MONICA PARTNERS LP

Patents where

Current Assignee

Name

is

Tocagen

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10035983 Gene therapy vectors and cytosine deaminases	Patent 10035983 was granted and assigned to Tocagen on July, 2018 by the United States Patent and Trademark Office.	Tocagen	Tocagen		United States Patent and Trademark Office	10035983	July 31, 2018
	‌ US Patent 10407666 Recombinant vectors	Patent 10407666 was granted and assigned to Tocagen on September, 2019 by the United States Patent and Trademark Office.	Tocagen	Tocagen		United States Patent and Trademark Office	10407666	September 10, 2019
	‌ US Patent 8722867 Gene therapy vectors and cytosine deaminases	Patent 8722867 was granted and assigned to Tocagen on May, 2014 by the United States Patent and Trademark Office.		Tocagen		United States Patent and Trademark Office	8722867	May 13, 2014
	‌ US Patent 9320738 Formulations of 5-fluorocytosine and uses thereof	Patent 9320738 was granted and assigned to Tocagen on April, 2016 by the United States Patent and Trademark Office.		Tocagen		United States Patent and Trademark Office	9320738	April 26, 2016
	‌ US Patent 9889133 Formulations of 5-fluorocytosine and uses thereof	Patent 9889133 was granted and assigned to Tocagen on February, 2018 by the United States Patent and Trademark Office.	Tocagen	Tocagen		United States Patent and Trademark Office	9889133	February 13, 2018
	‌ US Patent 9663834 Retrovirus detection	Patent 9663834 was granted and assigned to Tocagen on May, 2017 by the United States Patent and Trademark Office.		Tocagen		United States Patent and Trademark Office	9663834	May 30, 2017
	‌ US Patent 10449194 Formulations of 5-fluorocytosine and uses thereof	Patent 10449194 was granted and assigned to Tocagen on October, 2019 by the United States Patent and Trademark Office.	Tocagen	Tocagen		United States Patent and Trademark Office	10449194	October 22, 2019
	‌ US Patent 9642921 Cancer combination therapy and recombinant vectors	Patent 9642921 was granted and assigned to Tocagen on May, 2017 by the United States Patent and Trademark Office.	Tocagen	Tocagen		United States Patent and Trademark Office	9642921	May 9, 2017
	‌ US Patent 10316333 Producer cells for replication competent retroviral vectors	Patent 10316333 was granted and assigned to Tocagen on June, 2019 by the United States Patent and Trademark Office.		Tocagen		United States Patent and Trademark Office	10316333	June 11, 2019
	‌ US Patent 9732326 Recombinant vectors	Patent 9732326 was granted and assigned to Tocagen on August, 2017 by the United States Patent and Trademark Office.	Tocagen	Tocagen		United States Patent and Trademark Office	9732326	August 15, 2017
	‌ US Patent 8829173 Recombinant vectors	Patent 8829173 was granted and assigned to Tocagen on September, 2014 by the United States Patent and Trademark Office.		Tocagen		United States Patent and Trademark Office	8829173	September 9, 2014
	‌ US Patent 9669049 Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders	Patent 9669049 was granted and assigned to Tocagen on June, 2017 by the United States Patent and Trademark Office.		Tocagen		United States Patent and Trademark Office	9669049	June 6, 2017

12 results

0 selected

12 results

0 selected